Original Research ArticleInternational Journal of Clinical Trials

Publication:
Evaluation of neo adjuvant chemotherapy response in patients with locally advanced breast cancer

Int J Clin Trials. 2020;7(1):32-34.DOI10.18203/2349-3259.ijct20200204

Thumbnail Image
View on the journal's website(opens in a new tab)

Abstract

Background Carcinoma of the breast from the very beginning has been a feared disease. Advanced disease is treated by neoadjuvant chemotherapy (NACT). With this, a study was conducted to evaluate the pathologic response to NACT in locally advanced breast cancer.

Methods Study was conducted in GSL Medical College, approved by institutional ethics committee, females aged >18 years with locally advanced breast cancer were included in the study. Female <18 years and breast cancer male were not considered. The dimensions are marked and size of the lump compared before and after NACT. Chi-square test was used to find out the significance of study parameters; p<0.05 was considered statistically significant.

Results Total 110 patients were included in the study, mean age was 50.63±10.76 years and 53% were in pre menopausal women. When pathological response was considered, 12.7% had complete response, 66.4% had partial response and 20.9% had no response to NACT; statistically there was significant difference between pre and post treatment tumor sizes (p<0.05).

Conclusions Most of the individuals belonged to premenopausal group. Tumour size showed significant decrease after NACT. The overall response rate (complete and partial) after NACT was significant in our study group.

Keywords

Affiliations

  1. Department of General Medicine, GSL Medical College, Rajahmundry, Andhra Pradesh
  2. Central Research Laboratory, GSL Medical College, Rajahmundry, Andhra Pradesh

Full item record